Sushil Beriwal, Vice President Varian Medical Affairs, shared a post on LinkedIn by the European Society for Radiotherapy and Oncology (ESTRO), adding.
“Practice changing work establishing advance technique like VMAT/IGRT and MRI based adaptive brachytherapy as standard of care for cervical cancer.
Happy to be part of this seminal clinical trial.”
Quoting ESTRO‘s post:
“EMBRACE II took the spotlight at ESTRO25 after winning the Donal Hollywood Award!
At ESTRO25, Prof Richard Pötter presented the overall results of EMBRACE II – a landmark, multi-centre prospective study in locally advanced cervical cancer.
This congress report explores how EMBRACE II sets a new benchmark for IGRT-IMRT + cisplatin + MR-IGABT, and why its protocol is poised to become the new standard of care.
The EMBRACE Collaborative Group received the prestigious Donal Hollywood Award in recognition of this outstanding achievement.
Read the full congress report.”
More from Sushil Beriwal on OncoDaily.